课题基金 / 基金详情

TRANSFORMING DOMAINS IN THE IGF-1 RECEPTOR

TRANSFORMING DOMAINS IN THE IGF-1 RECEPTOR
转变 IGF-1 受体中的结构域
批准号:
6189704
负责人:
CHRISTIAN SELL
金额:
$10.87万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-02-06 至 2001-01-31

项目摘要

项目成果

CHRISTIAN SELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have derived cell lines from mouse embryos homozygous for a targeted disruption of the insulin like growth factor type 1 receptor (IGF-1 R) gene (Lui et al. 1993, Baker et al. 1993). The cell lines from these IGF-1 R knockout mice and from wild type littermates (R- and W respectively) differ in their growth and relative ease of transformation. The R- cells, unlike W cells, do not undergo cell division in serum free medium supplemented with PDGF, EGF, IGF-1, and cannot be transformed by the introduction of the simian virus 40 (SV4O) large T antigen. The R- cells expressing the SV4O T antigen ((tsA)R-) retain the characteristics of normal fibroblasts in serum containing medium. Reintroduction of the wild type IGF-1 R into the tsAR- cells restores the transforming capacity of the SV4O T antigen. Preliminary data indicates that there are distinct signals generated by the IGF-1 R within the cell which are specific for DNA synthesis or proliferation (i.e. entry into mitosis) and that these signals may be separate from those needed for cellular transformation. A truncated IGF-1 R allows R-cells to proliferate in response to IGF-1 but does not allow transformation in (tsA)R- cells. In order to extend these results and to examine divergence of cellular signals at the level of the IGF-1 R we propose to introduce specific mutations in the receptor and to express these mutant receptors in R- and (tsA)R- cells. The ability of these mutant receptors to induce entry into S phase, mitosis and various aspects of transformation; i.e. foci formation, anchorage independent growth, and tumorigenicity, will be determined.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Downregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells.
毒胡萝卜素处理的人前列腺上皮细胞中 IRS-1 蛋白的下调。
DOI: 10.1016/s0014-4827(03)00286-6
发表时间: 2003
期刊: Experimental cell research
影响因子: 3.7
作者: [Zhang,Hong, Hoff,Henry, Sell,Christian]
通讯作者: Sell,Christian
A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts.
磷脂酰肌醇 3-激酶抑制剂可诱导人二倍体成纤维细胞出现衰老样生长停滞。
DOI: --
发表时间: 1998
期刊: Cancer research
影响因子: 11.2
作者: [Tresini,M, Mawal-Dewan,M, Cristofalo,VJ, Sell,C]
通讯作者: Sell,C
Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905.
通过删除氨基酸 870-905 激活胰岛素样生长因子 1 型受体。
DOI: 10.1006/excr.1998.4167
发表时间: 1998
期刊: Experimental cell research.
影响因子: --
作者: [Li,S, Zhang,H, Hoff,H, Sell,C]
通讯作者: Sell,C
Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells.
前列腺上皮细胞中的表皮生长因子可抑制胰岛素样生长因子 I 介导的胰岛素受体底物 1 的降解。
DOI: 10.1074/jbc.m000412200
发表时间: 2000
期刊: The Journal of biological chemistry
影响因子: --
作者: [Zhang,H, Hoff,H, Sell,C]
通讯作者: Sell,C
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10649541
  • 项目类别:
  • 资助金额:
    $41.39万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10446243
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10711017
  • 项目类别:
  • 资助金额:
    $38.51万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10358671
  • 项目类别:
  • 资助金额:
    $31.05万
  • 财政年份:
    2021
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
海外基金